BioMarin (BMRN) Jumps 17.7% on $5-Billion Merger with Amicus [Yahoo! Finance]
BioMarin Pharmaceutical Inc. (BMRN)
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.biomarin.com
Company Research
Source: Yahoo! Finance
BioMarin Pharmaceutical extended its winning streak to a third straight day on Friday, surging 17.71 percent to finish at $61.15 apiece, as investors took heart from its expansion initiatives following the acquisition of Amicus Therapeutics for nearly $5 billion. In a statement, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) said that it entered into a definitive agreement to acquire Amicus Therapeutics in an all-cash transaction at a price of $14.50 apiece, or a 33 percent premium over the latter's closing price on Thursday, December 18. The transaction will be funded through a combination of cash on hand and approximately $3.7 billion of non-convertible debt financing. The acquisition would support its commercial portfolio with the addition of Galafold, an oral treatment for Fabry disease, and Pombiliti + Opfolda, a two-component therapy for Pompe disease. Upon completion of the transaction, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) expects to increase its long-term CAGR throu
Show less
Read more
Impact Snapshot
Event Time:
BMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMRN alerts
High impacting BioMarin Pharmaceutical Inc. news events
Weekly update
A roundup of the hottest topics
BMRN
News
- BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target raised by analysts at HC Wainwright from $55.00 to $60.00. They now have a "neutral" rating on the stock.MarketBeat
- These Stocks Moved the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More [Yahoo! Finance]Yahoo! Finance
- Key deals this week: Trump Media & Technology, Howard Hughes, BioMarin Pharmaceutical and more [Seeking Alpha]Seeking Alpha
- Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today [Yahoo! Finance]Yahoo! Finance
- These Stocks Are Moving the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More [Yahoo! Finance]Yahoo! Finance
BMRN
Earnings
- 10/27/25 - Miss
BMRN
Sec Filings
- 12/19/25 - Form 8-K
- 12/17/25 - Form 8-K
- 12/2/25 - Form 4
- BMRN's page on the SEC website